Malignant hematologic diseases undergoing hematopoietic stem cell transplantation
Conditions
Interventions
GVHD group and- non-GVHD group:NA
Sponsors
Peking University People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Healthy donors and paired allo-HSCT recipients treated at Peking University Institute of Hematology, 2. Between 18 and 60 years old; 3. Subjects are able to provide written informed consent.
Exclusion criteria
Exclusion criteria: Subjects who cannot comply with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Graft-versus-host disease (GVHD); | — |
Secondary
| Measure | Time frame |
|---|---|
| Infection;Relapse;Non-relapsed mortality (NRM);Overall survival(OS); | — |
Countries
China
Contacts
Public ContactXiaosu Zhao
Peking University People’s Hospital
Outcome results
None listed